umu.sePublications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
TMPRSS2-ERG Expression Predicts Prostate Cancer Survival and Associates with Stromal Biomarkers
Umeå University, Faculty of Medicine, Department of Medical Biosciences, Pathology.
Umeå University, Faculty of Medicine, Department of Medical Biosciences, Pathology.
Umeå University, Faculty of Medicine, Department of Medical Biosciences, Pathology.
Show others and affiliations
2014 (English)In: PLoS ONE, ISSN 1932-6203, E-ISSN 1932-6203, Vol. 9, no 2, e86824- p.Article in journal (Refereed) Published
Abstract [en]

The TMPRSS2-ERG gene fusion is found in approximately half of all prostate cancers. The functional and prognostic significance of TMPRSS2-ERG is, however, not fully understood. Based on a historical watchful waiting cohort, an association between TMPRSS2-ERG, evaluated as positive immune staining, and shorter survival of prostate cancer patients was identified. Expression of ERG was also associated with clinical markers such as advanced tumor stage, high Gleason score, presence of metastasis and prognostic tumor cell markers such as high Ki67, pEGFR and pAkt. Novel associations between TMPRSS2-ERG and alterations in the tumor stroma, for example, increased vascular density, hyaluronan and PDGFR beta and decreased Caveolin-1, all known to be associated with an aggressive disease, were found. The present study suggests that the TMPRSS2-ERG fusion gene is associated with a more aggressive prostate cancer phenotype, supported by changes in the tumor stroma.

Place, publisher, year, edition, pages
2014. Vol. 9, no 2, e86824- p.
National Category
Medical and Health Sciences
Identifiers
URN: urn:nbn:se:umu:diva-87026DOI: 10.1371/journal.pone.0086824ISI: 000330829200028OAI: oai:DiVA.org:umu-87026DiVA: diva2:710633
Available from: 2014-04-07 Created: 2014-03-18 Last updated: 2017-12-05Bibliographically approved

Open Access in DiVA

fulltext(384 kB)155 downloads
File information
File name FULLTEXT01.pdfFile size 384 kBChecksum SHA-512
39ea1eff66ca4107bb241cc01dc840a4f326cb7e949df2cfdc69757c72ba05a37ab1995d24c39cf6caadf5c60c42ef036987d27fa757cd7dbf2529f12a92deba
Type fulltextMimetype application/pdf

Other links

Publisher's full text

Authority records BETA

Hägglöf, ChristinaHammarsten, PeterStrömvall, KerstinStattin, PärBergh, Anders

Search in DiVA

By author/editor
Hägglöf, ChristinaHammarsten, PeterStrömvall, KerstinStattin, PärBergh, Anders
By organisation
PathologyUrology and Andrology
In the same journal
PLoS ONE
Medical and Health Sciences

Search outside of DiVA

GoogleGoogle Scholar
Total: 155 downloads
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

doi
urn-nbn

Altmetric score

doi
urn-nbn
Total: 207 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf